参考文献/References:
[1] 李云桥,汪金峰,葛 晶.通过ROC曲线评估联合检测TnI,hs-CRP和NT-proBNP对老年急性冠状动脉综合征的诊断价值[J].临床心血管病杂志,2012,28(9):667-670.
Li YQ,Wang JF,Ge J.Diagnostic value of combined measurement of TnI,hs-CRP and NT-proBNP by ROC in elderly patients with acute coronary syndrome[J].Journal of Clincal Cardiology(China),2012,28(9):667-670.
[2] 张 平,周洪兴,白 阳,等.缺血修饰白蛋白在急性冠状动脉综合征早期诊断中的应用价值研究[J].检验医学,2015,30(6):581-584.
Zhang P,Zhou HX,Bai Y,et al.Study on the application significanceof ischemia-modified albumin in early dignosis of acute coronary syndrome[J].Laboratory Medicine,2015,30(6):581-584.
[3] Garrido IP,Roy D,Calvino R,et al.Comparison of ischemia-modified albumin levels in patients undergoing percutaneous coronary intervention for unstable angina pectoris with versus without coronary collaterals[J].Am J Cardiol,2004,93(1):88-90.
[4] Kavsak PA,MacRae AR,Lustig V,et al.The impact of the ESC/ACC redefinition of myocardial infarction and new sensitive troponin assays on the frequencyof acute myocardial infarction[J].American Heart Journal,2006,152(1):118-125.
[5] Bar-Or D,Lau E,Winkler JV.A novel assay for co-balt-albumin bindingand its potential as a marker for myocardial ischemia-a preliminary report[J].J Emerg Med,2000,19(4):311-315.
[6] Sinha MK,Roy D,Gaze DC,et al.Role of “ischemia modified albumin”,anew biochemical marker of myocardial ischaemia,in the early diagnosis of acutecoronary syndrome[J].Emerg Med J,2004,21(1):29-34.
[7] Toker A,Aribas A,Yerlikaya FH,et al.Serum and sa-liva levels of ischemia-modified albumin in patients with acute myocardial infarction[J].J ClinLab Anal,2013,27(2):99-104.
[8] 王亚平,姜宇海,吴雪江.缺血修饰清蛋白对急性冠脉综合征的诊断价值[J].临床检验杂志,2008,26(6):456.
Wang YP,Jiang YH,Wu XJ.The dignostic value of ischemia-modifiedalbumin on acute coronary syndrome[J].Chinese Journal of Clincal LaboratoryScience,2008,26(6):456.
[9] 熊 军,龙 聪,范 文,等.探讨缺血修饰清蛋白在ACS早期的诊断意义[J].现代检验医学杂志,2011,26(3):102-104.
Xiong J,Long C,Fan W,et al.Exploring the clinical diagnostic value of serum ischemia modified albumin in early acute coronary syndrome[J].Journal of Modern Laboratory Medicine,2011,26(3):102-104.
[10] Zahorec R.Ratio of neutrophil to lymphocyte cou-nts-rapid andsimple parameter of systemic inflammation and stress in critically ill[J].Bratisl Lek Listy,2001,102(1):5-14.
[11] Acar G,Fidan S,Uslu ZA,et al.Relationship of neutrophil-lymphocyteratio with the presence,severity,and extent of coronary atherosclerosis detected by coronary computed tomography angiography[J].Angiology,2015,66(2):174-179.
[12] Azab B,Chainani V,Shah N,et al.Neutrophil-lymphocyte ratio as a predictor of major adverse cardiac events among diabetic population:a 4-year follow-up study[J].Angiology,2013,64(6):456-465.
[13] Arbel Y,Finkelstein A,Halkin A,et al.Neutrophil/lymphocyte ratio isrelated to the severity of coronary artery disease and clinical outcome in patients undergoing angiography[J].Atherosclerosis,2012,225(2):456-460.
[14] Cicek G,Acikgoz SK,Bozbay M,et al.Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio combination can predict prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention[J].Angiology,2015,66(5):441-447.
[15] Sahin DY,Elbasan Z,Gur M,et al.Neutrophil to lymphocyte ratio is associated with the severity of coronary artery disease in patients with ST-segment elevation myocardial infarction[J].Angiology,2013,64(6):423-429.
[16] He J,Li J,Wang Y,et al.Neutrophil-to-lymphocyte ratio(NLR)predicts mortality and adverse-outcomes after ST-segment elevation myocardial infarction in Chinese people[J].Int J Clin Exp Pathol,2014,7(7):4045-4056.
[17] Han YC,Yang TH,Kim DI,et al.Neutrophil to lymphocyte ratio predictslong-term clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention[J].Korean Circ J,2013,43(2):93-99.
[18] Wang XH,Liu SQ,Wang YL,et al.Correlation of serum high-sensitivityC-reactive protein and interleukin-6 in patients with acute coronary syndrome[J].Genet Mol Res,2014,13(2):4260-4266.
[19] Chawla R,Goyal N,Calton R,et al.Ischemia modified albumin: A novelmarker for acute coronary syndrome[J].Indian J Clin Biochem,2006,21(1):77-82.
相似文献/References:
[1]史剑飞,卢北玲,李 俏,等.西安地区健康儿童血清缺血修饰清蛋白参考区间的建立[J].现代检验医学杂志,2019,34(06):118.[doi:10.3969 / j.issn.1671-7414.2019.06.029]
SHI Jian-fei,LU Bei-ling,LI Qiao,et al.Establishment of Reference Interval for Serum Ischemic Modified Albumin of
Healthy Children in Xi’an Area[J].Journal of Modern Laboratory Medicine,2019,34(05):118.[doi:10.3969 / j.issn.1671-7414.2019.06.029]
[2]马飞艳,王 娟,樊 萍.川崎病患儿血清趋化素和缺血修饰清蛋白水平与冠状动脉损伤的相关性及在治疗中的应用价值[J].现代检验医学杂志,2021,36(03):72.[doi:10.3969/j.issn.1671-7414.2021.03.016]
MA Fei-yan,WANG Juan,FAN Ping.Relationship between the Levels of Chemokine and Ischemia-modified Albuminin Serum and Coronary Artery Injury in Children with Kawasaki Disease and the Application Value in the Treatment[J].Journal of Modern Laboratory Medicine,2021,36(05):72.[doi:10.3969/j.issn.1671-7414.2021.03.016]